Research budget in pharmaceutical industry
Revision as of 19:52, 15 September 2009 by Peter Friedl (talk | contribs)
This page is under construction and edited by Peter Friedl EMBA09. In case of any questions/remarks, feel free to contact me
Description:
In the pharmaceutical industry research and development is a very time-consuming and demanding task. Only a few new drugs make it through development, testing and product approval each year. This asks for a large R&D budget over several years for pharmaceutical companies. Even then a success, the development of a new, good selling drug, is of course not guaranteed.
Enablers:
- Size of the pharmaceutical company
- Revenue streams of the company
- Marketability of pharmaceuticals
- Intellectual Property rights for pharmaceuticals (link to driving force IP rights)
- Funding of the health system
- General prosperity
Inhibitors:
- Unstable and unpredictable general economic conditions
Paradigms:
Experts:
Timing:
Web Resources:
- [1] Pharmaceutical Corporations and Medical Research - article on Global Issues
- [2] R&D in the Pharmaceutical Industry - a Congressional Budget Office Study